Article Figures & Data
Tables
- Table 1.
Characteristics of Patients with Opioid Use Disorder, Total, and by Medication-Assisted Treatment Initiation Versus No MAT Initiation
Patient Characteristics Total MAT Initiation No MAT Initiation P Value N (%) N (%) N (%) Total 1638 542 (33.1) 1096 (66.9) Urban/rural .5776 Urban 1222 (74.6) 404 (74.5) 818 (74.6) Rural 416 (25.4) 138 (25.5) 278 (25.4) Sex .2946 Male 658 (40.2) 208 (38.4) 450 (41.1) Female 980 (59.8) 334 (61.6) 646 (58.9) Age as of date of first MAT prescription <.0001 18 to 29 332 (20.3) 149 (27.5) NA 30 to 49 791 (48.3) 282 (52.0) NA 50+ 515 (31.4) 111 (20.5) NA Race/Ethnicity (detail) .5064 Hispanic 46 (2.8) 16 (2.9) 30 (2.7) NH white 1358 (82.9) 457 (84.3) 901 (82.2) NH other 52 (3.2) 12 (2.2) 40 (3.6) NH black 94 (5.7) 24 (4.4) 70 (6.4) Unknown 88 (5.4) 33 (6.1) 55 (5.0) Race/Ethnicity (for analysis) .0106 NH white 1358 (82.9) 457 (84.3) 901 (82.2) Other 280 (17.1) 85 (15.7) 195 (17.8) Insurance coverage at majority of visits in study year <.0001 Commercial 128 (7.8) 65 (11.9) 63 (5.79) Medicaid 977 (59.6) 315 (58.1) 662 (60.9) Medicare 222 (13.6) 45 (8.3) 177 (16.3) Self-pay 302 (18.4) 116 (21.4) 186 (17.1) Other <10 <10 <10 Comorbidities Hypertension 463 (28.3) 110 (20.3) 353 (32.2) .0215 Diabetes 166 (10.1) 27 (4.9) 139 (12.7) .0011 Asthma/COPD 360 (21.9) 86 (15.9) 274 (25.0) <.0001 Coronary artery disease 62 (3.8) <10 55 (5.02) .0020 Lipid disorder 251 (15.3) 50 (9.2) 201 (18.3) <.0001 Cancer 130 (7.9) 27 (4.9) 103 (9.4) .0029 HIV <10 0 <10 .5380 Hepatitis C 174 (10.6) 50 (9.2) 124 (11.3) .0331 Psychiatric disorder* 1204 (73.5) 419 (77.3) 785 (71.6) .0106 Current tobacco use at ≥1 visit 948 (57.9) 386 (71.2) 562 (51.3) <.0001 NA, Not applicable; NH, Non-Hispanic; COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; MAT, Medication-Assisted Treatment.
↵* Psychiatric disorders included anxiety disorders, posttraumatic stress disorder, schizophrenia and other psychotic disorders, depressive disorders, and bipolar disorder.
- Table 2.
Adjusted Odds Ratios of Medication-Assisted Treatment Initiation for Opioid Use Disorder by Patient Characteristics (n = 1638)*
Characteristic Odds Ratio 95% Confidence Interval P Value Sex Male Ref Female (ref: male) 1.04 0.82, 1.30 0.7719 Age as of date of first MAT prescription 0.0030 18 to 29 Ref 30 to 49 0.77 0.58, 1.01 50+ 0.54 0.38, 0.77 Race/Ethnicity 0.7528 Non-Hispanic white Ref Other 0.95 0.71, 1.28 Insurance coverage at majority of visits in study period <0.0001 Commercial Ref Medicaid 0.38 0.26, 0.57 Medicare 0.31 0.18, 0.53 Self-pay 0.53 0.34, 0.83 Comorbidities† Hypertension 0.89 0.67, 1.19 0.4495 Diabetes 0.56 0.35, 0.89 0.0135 Asthma/COPD 0.70 0.53, 0.94 0.0186 Coronary artery disease 0.54 0.24, 1.26 0.1537 Lipid disorder 0.71 0.49, 1.03 0.0714 Cancer 0.68 0.43, 1.09 0.1084 Hepatitis C 0.73 0.51, 1.05 0.0934 Psychiatric disorder‡ 1.62 1.25, 2.10 0.0003 Current tobacco use at ≥1 visit 2.46 1.95, 3.12 <0.0001 COPD, chronic obstructive pulmonary disease. MAT, medication-assisted treatment.
↵* Bolded values denote statistical significance at P < .05.
↵† Reference for each comorbid condition is the absence of the condition.
↵‡ Psychiatric disorders included anxiety disorders, posttraumatic stress disorder, schizophrenia and other psychotic disorders, depressive disorders, and bipolar disorder.
